Patents by Inventor Francis Muller

Francis Muller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060276503
    Abstract: The present invention provides a novel process for preparing pleuromutilin derivatives, novel salts of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or solvates thereof, novel pharmaceutical compositions or formulations for topical administration comprising mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or a pharmaceutically acceptable salt or solvate thereof and their use in medical therapy, particularly antibacterial therapy.
    Type: Application
    Filed: August 30, 2004
    Publication date: December 7, 2006
    Inventors: Gary Breen, Michael Forth, Susan Kopelman, Francis Muller, Francis Sanderson
  • Patent number: 5573906
    Abstract: A process for the detection of a nucleic acid sequence in a homogeneous assay format using an energy transfer system is disclosed. This process utilizes a 5' labeled primer containing a selfcomplementary sequence in an amplification or extension process together with a subsequent detection step using a 3' labeled probe for the amplified or extended region. The labels will be close together in space after hybridizing the probe close to the short piece of double-stranded DNA resulting from backfolding of the selfcomplementary region of the primer which has been incorporated into the amplified or extended product. A new primer for use in this process is also disclosed.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: November 12, 1996
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wilhelm Bannwarth, Francis Muller
  • Patent number: 5278043
    Abstract: Energy-transfer systems which can be used, inter alia, for measuring distances within or between different molecules are described, comprising derivatives of lumazine and ruthenium, in particular derivatives of DNA or RNA sequences.
    Type: Grant
    Filed: January 22, 1991
    Date of Patent: January 11, 1994
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Wilhelm Bannwarth, Francis Muller
  • Patent number: 5075447
    Abstract: The invention relates to a ruthenium complex having the formulaRu.sup.2+ L.sub.1 L.sub.2 L.sub.3 Iwherein L.sub.1, L.sub.2 and L.sub.3 are the same or different are equal to a bi- or polycyclic ligand with at least two nitrogen-containing heterocycles, whereby at least one of these ligands is substituted with at least one group conferring water-solubility, and whereby at least one of these ligands is substituted, optionally via a spacer group, with at least one reactive group, and whereby the ligands L.sub.1, L.sub.2 and L.sub.3 are attached to the ruthenium via nitrogen atoms.The invention is further related to such ruthenium complexes having coupled thereto an immunologically active material, for example, antigens, haptens or antibodies and to the use of said ruthenium complexes in fluorescence spectroscopy. Specific ligands L.sub.1, L.sub.2 and L.sub.3 which are useful in the ruthenium complexes of the invention are, e.g.
    Type: Grant
    Filed: February 8, 1988
    Date of Patent: December 24, 1991
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Francis Muller, Dieter Schmidt
  • Patent number: 4835438
    Abstract: Spin polarized electron source using an emissive micropoint cathode. At least one portion of each micropoint, including the top of the latter, is ferromagnetic, so that the electrons emitted by the cathode are spin polarized in a given direction, when the portion is subject to a magnetic field parallel to the given direction.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: May 30, 1989
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Robert Baptist, Ariel Brenac, Gerard Chauvet, Robert Meyer, Francis Muller
  • Patent number: 4745076
    Abstract: The invention relates to a ruthenium complex having the formulaRu.sup.2+ L.sub.1 L.sub.2 L.sub.3 Iwherein L.sub.1, L.sub.2 and L.sub.3 are the same or different are equal to a bi- or polycyclic ligand with at least two nitrogen-containing heterocycles, whereby at least one of these ligands is substituted with at least one group conferring water-solubility, and whereby at least one of these ligands is substituted, optionally via a spacer group, with at least one reactive group, and whereby the ligands L.sub.1, L.sub.2 and L.sub.3 are attached to the ruthenium via nitrogen atoms.The invention is further related to such ruthenium complexes having coupled thereto an immunologically active material, for example, antigens, haptens or antibodies and to the use of said ruthenium complexes in fluorescence spectroscopy. Specific ligands L.sub.1, L.sub.2 and L.sub.3 which are useful in the ruthenium complexes of the invention are, e.g.
    Type: Grant
    Filed: September 9, 1985
    Date of Patent: May 17, 1988
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Francis Muller, Dieter Schmidt
  • Patent number: 4639090
    Abstract: The display comprises a cholesteric liquid crystal film in which are embedded dye molecules between the two walls separated by a shim. One wall is at least partly covered by a reflecting coating reversing the polarization of a circularly polarized electromagnetic wave. The optical anisotropy .DELTA.n and the helix pitch p are such that the least absorbed wave on passing through the cell has an ellipticity equal to or greater than .pi./8.
    Type: Grant
    Filed: May 22, 1985
    Date of Patent: January 27, 1987
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jean-Frederic Clerc, Francis Muller